|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:Searle_Pharmaceuticals
|
|
gptkbp:activities
|
dopamine reuptake inhibitor
|
|
gptkbp:approves
|
gptkb:historical_event
gptkb:1998
gptkb:FDA
weight loss
schizophrenia
bipolar disorder
|
|
gptkbp:brand
|
gptkb:Modavigil
Vigil
Alertec
|
|
gptkbp:class
|
wakefulness-promoting agent
|
|
gptkbp:contraindication
|
liver impairment
history of heart problems
hypersensitivity to modafinil
|
|
gptkbp:developed_by
|
gptkb:Cephalon
|
|
gptkbp:discovered_by
|
1990s
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Modafinil
|
|
gptkbp:ingredients
|
C15 H15 N O2 S
|
|
gptkbp:interacts_with
|
gptkb:warfarin
oral contraceptives
certain antidepressants
|
|
gptkbp:is_available_in
|
many countries
|
|
gptkbp:is_available_on
|
gptkb:tablet
|
|
gptkbp:is_used_for
|
gptkb:shift_work_sleep_disorder
narcolepsy
obstructive sleep apnea
|
|
gptkbp:legal_issue
|
prescription only
|
|
gptkbp:lifespan
|
12-15 hours
|
|
gptkbp:marketed_as
|
gptkb:Provigil
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:research
|
depression treatment
cognitive enhancement
fatigue management
ADHD treatment
|
|
gptkbp:side_effect
|
anxiety
headache
nausea
insomnia
|
|
gptkbp:type_of
|
68693-11-8
|